Catalog No.
DHA30604
Expression system
Mammalian Cells
Species reactivity
Human
Host species
Human
Isotype
IgG1-nd
Clonality
Monoclonal
Target
GDF-8, GDF8, MSTN, Myostatin, Growth/differentiation factor 8
Concentration
1 mg/ml
Endotoxin level
Please contact with the lab for this information.
Purity
>95% as determined by SDS-PAGE.
Purification
Protein A/G purified from cell culture supernatant.
Accession
O14793
Applications
Research Grade Biosimilar
Form
Liquid
Storage buffer
0.01M PBS, pH 7.4.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.
Alternative Names
MYO-029, CAS: 705287-60-1
Clone ID
Stamulumab
Detecting peptidic drugs, drug candidates and analogs in sports doping: current status and future directions, PMID: 25382550
Are big muscles necessarily good muscles?, PMID: 18481287
Therapies for musculoskeletal disease: can we treat two birds with one stone?, PMID: 24633910
Analytical approaches for the detection of emerging therapeutics and non-approved drugs in human doping controls, PMID: 24906629
[Anti-myostatin antibody therapy for myopathies], PMID: 22277518
Translational Pharmacokinetic/Pharmacodynamic Analysis of MYO-029 Antibody for Muscular Dystrophy, PMID: 27700008
Functional improvement of dystrophic muscle by myostatin blockade, PMID: 12459784
A phase I/IItrial of MYO-029 in adult subjects with muscular dystrophy, PMID: 18335515
Single muscle fiber contractile properties in adults with muscular dystrophy treated with MYO-029, PMID: 19086063
[Therapeutic strategies for muscular dystrophy by myostatin inhibition], PMID: 17432227
For research use only. Not for human or drug use.
